Euronext Paris · Healthcare
Invest in Bluelinea stock from India
Indian and foreign residents can buy Bluelinea (ALBLU) shares directly through Paasa.
By Paasa · Updated
Bluelinea at a glance
- Price
- €0.14-€0.00 (2.86%)
- Market cap
- €2.50M
- Day range
- €0.14 – €0.15
- P/E
- -1.37
- Dividend yield
- None
- Volume
- 1.60K
- 1 month
- -24.44%
- 6 months
- -70.56%
- YTD
- -72.24%
- 1 year
- -72.24%
- 5 years
- -97.00%
Bluelinea statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €10.4M | €9.4M | €9.9M | €10.4M | €7.5M |
| Gross profit | −€1.3M | −€1.1M | €6.0M | −€724.1K | −€3.0M |
| Operating income | −€1.3M | −€1.2M | −€1.6M | −€840.6K | −€3.2M |
| Net income | −€1.5M | −€1.3M | −€1.6M | −€1.5M | −€3.3M |
| Earnings per share | −€0.08 | −€0.10 | −€0.00 | −€0.12 | −€0.54 |
| EBITDA | €787.4K | €789.8K | €98.2K | €74.4K | −€2.6M |
| Total assets | €9.2M | €9.4M | €10.8M | €13.2M | €8.1M |
| Total debt | €3.3M | €4.3M | €3.6M | €3.6M | €4.0M |
| Cash and short-term investments | €821.9K | €579.5K | €1.0M | €4.6M | €771.2K |
| Shareholders' equity | €2.9M | €1.4M | €2.7M | €4.3M | −€1.9M |
| Operating cash flow | −€758.7K | €857.9K | −€644.4K | −€1.0M | −€565.5K |
| Free cash flow | −€1.7M | −€1.1M | −€3.6M | −€2.7M | −€1.4M |
| Capital expenditure | −€980.2K | −€2.0M | −€3.0M | −€1.7M | −€844.8K |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Mauna Kea Technologies | ALMKT.PA | €0.15 | €28.47M |
| Biosynex | ALBIO.PA | €0.89 | €16.48M |
| Euromedis Groupe | ALEMG.PA | €5.20 | €14.85M |
| Intrasense | ALINS.PA | €0.22 | €11.59M |
| TME Pharma | ALTME.PA | €0.10 | €9.80M |
| SpineGuard | ALSGD.PA | €0.09 | €8.82M |
| AMA | ALAMA.PA | €0.16 | €8.30M |
| Media Lab | MLLAB.PA | €2.48 | €5.88M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Bluelinea from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search ALBLU and buy
Find Bluelinea by name or by its ticker, ALBLU, and place your order.
Why invest in Bluelinea from India
What Bluelinea does
Bluelinea Société Anonyme, established in 2006 and based in Elancourt, France, specializes in delivering a variety of healthcare solutions to support elderly and disabled individuals across France. Their comprehensive product portfolio encompasses SERENEA, a dedicated nursing call system, and BluePhone, a mobile device offering remote assistance specifically for seniors. Bluelinea operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Bluelinea stock from India?
Yes. Indian residents and NRIs can buy Bluelinea (ALBLU) shares directly through Paasa. Bluelinea is listed on Euronext Paris, in the Medical - Devices industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell Bluelinea shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.